Early-stage ovarian cancer: Clinical outcome and analysis of prognostic factors—Results from a prospective registry of GEICO (Spanish Group for Ovarian Cancer Research). This is an ASCO Meeting ...
Phase II clinical trial evaluating CRLX101 in recurrent ovarian, tubal, and peritoneal cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a ...